P706: ASCIMINIB USE IN CML: THE UK EXPERIENCE von Innes, A., Orovboni, V., Claudiani, S., Fernando, F., Khan, A., Byrne, J., Gallipoli, P., Copland, M., Horne, G., Arnold, C., Collins, A., Cunningham, N., Danga, A., Frewin, R., Garland, P., Hannah, G., Hassan, S., Makkuni, S., Rothwell, K., Foroni, L., Hayden, C., Apperley, J., Milojkovic, D.

Volltext

Impact of BCR::ABL1 single nucleotide variants on 1 asciminib efficacy von Innes, A, Hayden, C, Orovboni, V, Claudiani, S, Fernando, F, Khan, A, Rees, D, Byrne, J, Gallipoli, P, Francis, S, Copland, M, Horne, G, Raghavan, M, Arnold, C, Collins, A, Cranfield, T, Cunningham, N, Danga, A, Forsyth, P, Frewin, R, Garland, P, Hannah, G, Avenoso, D, Hassan, S, Huntly, B, Husain, J, Makkuni, S, Rothwell, K, Khorashad, J, Apperley, J, Milojkovic, D

Volltext